glp 1 receptor agonists beyond their pancreatic effects GLP-1 are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read GLP1 Receptor Agonists—Effects beyond Obesity

Description

10.14336/AD.2023.0118 82 RosenstockJ.WyshamC.FriasJ

GLP-1s for Alcohol Use Disorder (AUD) Early research has included investigations to determine whether GLP-1 might be an effective treatment for AUD

Health Canada warns about fake or unauthorized versions of GLP-1 drugs Health Canada says it has found retailers in Canada selling unauthorized GLP-1 products Health Canada is warning people not to buy or use fake or unauthorized versions of GLP-1 drugs such as semaglutide, the active ingredient in Ozempic and Wegovy

A nationwide register-based cohort and self-controlled case series study

As summed up by industry experts: technology transfer is a pivotal navigational strategy enabling companies to adapt quickly to changes in demand, regulatory policies, or market dynamics